NCT00600015 Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2
NCT00598507 Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma Status COMPLETED Phase PHASE2
NCT00589420 Sorafenib and Docetaxel in Patients With Prostate Cancer That Did Not Respond to Previous Hormone Therapy Status COMPLETED Phase PHASE2
NCT00586521 BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) Status COMPLETED Phase PHASE4
NCT00586105 Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC) Status COMPLETED Phase PHASE3
NCT00576056 Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC Status TERMINATED Phase PHASE2
NCT00572078 Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00571649 Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients Status COMPLETED Phase PHASE3
NCT00568945 Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation. Status COMPLETED Phase PHASE2
NCT00568412 A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE4
NCT00567164 Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ Status COMPLETED Phase PHASE3
NCT00566384 Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido Status COMPLETED Phase PHASE2
NCT00565565 Single Dose Escalation Study in Patients With Chronic Heart Failure Status COMPLETED Phase PHASE1
NCT00562913 Phase I Study of Sorafenib Dosed Continuously With Cyclophosphamide and Doxorubicin Status COMPLETED Phase PHASE1
NCT00561717 A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis Status COMPLETED Phase PHASE4